Muc-1 levels are elevated in the majority of patients with PC, and Muc-1 plays a key role that affects oncogenesis and the motility, metastasis, metabolism, and growth of cancer cells [43, 44]. The gene discussed is MUC1; the disease is pachyonychia congenita.